Financière de Tubize SAのQuick ratio
Financière de Tubize SAのQuick ratioは何ですか。
Financière de Tubize SAのQuick ratioは0.01です。
Quick ratioの定義は何ですか。
当座比率は、短期債務を即座に満たすために迅速な資産を使用する企業の能力を測定する流動性比率です。
The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.
EURONEXTのセクタHealth CareにおけるQuick ratioの企業と比べるFinancière de Tubize SA
Financière de Tubize SAは何をしますか。
Financière de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's principal products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Zyrtec and Xyzal for the treatment of allergy; Nootropil for the treatment of psycho-organic syndromes or cognitive decline and cortical myoclonus; and Xyrem for use in treating narcolepsy with cataplexy in adult patients. The company's products in pipeline include padsevonil for drug resistant epilepsy; UCB0107 for treating progressive supranuclear palsy; UCB0599 for Parkinson's disease; UCB7858 for auto-inflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize S.A. is based in Brussels, Belgium.
Financière de Tubize SAと類似のquick ratio
- Bassari ResourcesのQuick ratioは0.01です。
- Cotinga PharmaceuticalsのQuick ratioは0.01です。
- Nextpoint IncのQuick ratioは0.01です。
- Ceres AcquisitionのQuick ratioは0.01です。
- Bankers CobaltのQuick ratioは0.01です。
- SagalioのQuick ratioは0.01です。
- Financière de Tubize SAのQuick ratioは0.01です。
- Leaf of Faith BeverageのQuick ratioは0.01です。
- Integrated Rail and Resources AcquisitionのQuick ratioは0.01です。
- Jerrick MediaのQuick ratioは0.01です。
- Sparta Commercial ServicesのQuick ratioは0.01です。
- Primo NutraceuticalsのQuick ratioは0.01です。
- Blue Coast HotelsのQuick ratioは0.01です。